EHR alerts drive better HPV vaccine compliance

Alerts in EHR systems that prompt providers to begin or continue the human papilloma virus (HPV) vaccination with pediatric patients lead to an increased rate of protection against cervical cancer, according to a study published in the Journal of the American Board of Family Medicine.

The HPV vaccine is administered in three separate injections but about 85 percent of patients miss at least one opportunity to receive the vaccine while visiting their provider for another service, according to the study.

Researchers assigned 15,000 patients to two groups--one group was treated by providers with EHRs with HPV vaccine alerts and the other group by providers without those alerts.

Providers with EHR systems equipped with the alert were instructed to indicate where the patient was in the process of receiving the vaccination. The alerts increased the incidence of vaccination and helped improve the timeliness of doses.

When providers used EHR systems with the alerts, patients ages 9 to 18 were three times more likely to begin the series of HPV vaccine injections and 10 times more likely to complete the series, the researchers found. Patients ages 19 to 26 were six times more likely to begin the series and eight times more likely to complete it.

The researchers also found the reminders were especially effective for increasing the vaccination rate among blacks, who have been less likely to get the vaccine.

Beth Walsh,

Editor

Editor Beth earned a bachelor’s degree in journalism and master’s in health communication. She has worked in hospital, academic and publishing settings over the past 20 years. Beth joined TriMed in 2005, as editor of CMIO and Clinical Innovation + Technology. When not covering all things related to health IT, she spends time with her husband and three children.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.